seri
prepar
modifi
condens
correspond
monosubstitut
malon
acid
diester
guanidin
excess
sodium
ethoxid
optim
procedur
use
vilsmeierhaackarnold
reagent
follow
immedi
deprotect
dimethylamino
methylen
protect
group
develop
convert
analog
novel
high
yield
pilot
screen
biolog
properti
prepar
compound
done
mous
periton
cell
use
vitro
nitric
oxid
assay
irrespect
substitu
posit
inhibit
immuneactiv
product
effect
ic
lm
higher
activ
potent
refer
compound
ic
deriv
within
rang
lm
counterpart
devoid
noinhibitori
activ
compound
suppress
effect
viabil
cell
mechan
action
remain
elucid
work
initi
motiv
find
inhibit
replic
broad
rang
virus
member
herp
picorna
pox
group
marciali
et
al
marciali
et
al
la
colla
et
al
report
matur
viral
particl
prevent
viral
protein
synthes
presenc
compound
assembl
new
virion
la
colla
et
al
marciali
et
al
repres
uniqu
attract
mechan
action
new
antivir
drug
especi
combin
antivir
agent
aim
suppress
resist
develop
pyrimidin
heterocycl
element
structur
motif
sever
essenti
natur
product
undheim
bennech
ralev
burnstock
lagoja
number
synthet
drug
also
report
suppress
product
chicken
macrophag
sung
et
al
larg
class
pharmacolog
import
pyrimidin
deriv
act
dihydrofol
reductas
dhfr
inhibitor
hitch
well
compound
antihiv
de
clercq
antiadenoviru
naesen
et
al
antihbv
activ
ying
et
al
inhibitor
tetrahydrobiopterin
synthesi
kolinski
gross
regul
pain
sensit
persist
teged
et
al
antidepress
arvan
et
al
compound
suppress
accumul
cytokineinduc
nfjb
ikemoto
et
al
inhibitor
egfr
tyrosin
kinas
suzuki
et
al
cyclindepend
kinas
potenti
drug
candid
cancer
therapi
beatti
et
al
breault
et
al
substitut
posit
pyrimidin
moieti
use
past
improv
biolog
properti
sever
pharmacolog
interest
pyrimidin
deriv
antihiv
et
al
et
al
antiinfluenza
activ
jansa
et
al
inhibitori
activ
human
thymidin
phosphorylas
nencka
et
al
antioxid
activ
et
al
b
aim
present
studi
prepar
pilot
screen
intrins
biolog
potenti
substitu
posit
pyrimidin
ring
design
probe
posit
standard
homolog
seri
alkyl
substitu
studi
steric
requir
posit
eg
length
branch
satur
desatur
possibl
antivir
activ
compound
influenc
immuneactiv
high
output
nitric
oxid
product
analyz
assay
employ
capac
indic
posit
neg
interfer
compound
cell
immun
respons
includ
secret
cytokin
cytotox
et
al
harmatha
et
al
first
scheme
prepar
condens
properli
substitut
malon
acid
diester
guanidin
basic
condit
despit
fact
reaction
wellknown
literatur
rembold
schramm
baraldi
et
al
patel
et
al
rostom
et
al
optim
reaction
condit
case
crucial
impact
isol
yield
puriti
product
especi
multigram
scale
detail
see
experiment
follow
key
find
methanol
ethanol
requir
solvent
achiev
full
convers
clean
reaction
profil
alcohol
abl
least
partial
dissolv
product
otherwis
precipit
quantiti
quickli
preclud
stir
addit
water
reaction
dissolv
sodium
salt
product
subsequ
neutral
acet
acid
requir
keep
excess
guanidin
solut
product
quantit
precipit
neutral
solut
second
step
synthesi
target
scheme
consist
transform
moieti
residu
reaction
chlorid
miner
acid
pocl
pcl
socl
cocl
divers
addit
like
dmf
pyridin
diphenylamin
triethylamin
gener
use
altenbach
et
al
jang
et
al
nevertheless
classic
procedur
turn
unsuit
prepar
desir
owe
complic
isol
low
isol
yield
max
synthet
issu
resolv
applic
modifi
synthet
procedur
prepar
dimethylamino
methylen
amino
pyrimidin
dalug
et
al
use
vilsmeierhaackarnold
reagent
reichardt
follow
immedi
deprotect
dimethylamino
methylen
protect
group
gave
final
compound
scheme
final
step
carri
accord
method
describ
literatur
dalug
et
al
modifi
order
obtain
directli
reaction
mixtur
simpl
precipit
filtrat
detail
see
experiment
none
compound
show
antivir
activ
ec
lgml
toward
follow
virus
cem
cell
hcmv
vaccinia
viru
vesicular
stomat
viru
vsv
hela
cell
felin
herp
viru
felin
corona
viru
fipv
crfk
cell
vsv
coxsacki
viru
respiratori
syncyti
viru
rsv
hela
cell
parainfluenza
coxsacki
viru
punta
toro
viru
mdck
cell
parent
also
test
antivir
activ
observ
ec
lgml
import
mention
antivir
activ
describ
literatur
compound
requir
rel
high
concentr
rang
lgml
marciali
et
al
la
colla
et
al
vitro
stimul
mous
periton
cell
lp
plu
ifnc
substanti
enhanc
biosynthesi
concentr
nitrit
vari
lm
lm
mean
sem
variou
experi
spontan
product
control
cell
neglig
rang
lm
lm
mean
sem
individu
experi
none
lm
concentr
significantli
influenc
f
p
ifnlpsactiv
biosynthesi
fig
averag
format
nitrit
drop
control
valu
compound
remain
ineffect
even
fourfold
higher
ie
lm
concentr
data
shown
contrast
appli
lm
concentr
suppress
product
least
fig
effect
highli
statist
signific
f
p
effect
suppress
product
strictli
dosedepend
fig
effect
alreadi
appar
concentr
lm
ic
estim
tabl
rang
lm
lm
respect
noinhibitori
effect
test
pyrimidin
compar
effect
recogn
noinhibitor
fig
effect
prove
w
least
effect
aminoguanidin
correspond
ic
shown
tabl
good
agreement
activ
report
previous
xu
krukoff
appli
lm
concentr
compound
statist
signific
influenc
viabil
cell
fig
differ
two
group
pyrimidin
deriv
observ
f
p
optim
synthet
procedur
prepar
start
monosubstitut
malon
acid
diester
develop
final
compound
inhibit
product
mous
periton
cell
compound
potent
frequent
use
inhibitor
product
n
g
monomethyllarginin
effect
compound
bear
fluorin
atom
posit
pyrimidin
ring
nearli
complet
suppress
product
exhibit
higher
activ
potent
refer
compound
w
interest
discoveri
inhibitori
effect
product
vitro
repres
initi
hit
develop
potent
compound
antiinflammatori
activ
patent
pend
compound
next
gener
vitro
vivo
data
publish
elsewher
unless
state
otherwis
solvent
evapor
kpa
compound
dri
pa
analyt
tlc
perform
silica
gel
f
plate
merck
kgaa
darmstadt
germani
nmr
spectra
measur
ft
nmr
spectromet
bruker
avanc
ii
dmsod
h
mhz
c
mhz
referenc
residu
solvent
signal
chemic
shift
express
part
per
million
ppm
interact
constant
j
hz
gcm
analys
measur
use
n
ga
chromatograph
agil
santa
clara
ca
usa
attach
quadrupol
mass
detector
ms
capillari
mm
lm
agil
use
analys
carrier
ga
helium
flow
rate
mlmin
ei
mass
spectra
measur
gct
premier
water
oatof
gc
mass
spectromet
element
composit
prepar
compound
determin
use
pe
seri
ii
chn
element
analyz
perkin
elmer
usa
melt
point
determin
stuart
melt
point
apparatu
uncorrect
compound
prepar
accord
literatur
schostarez
compound
purchas
sigmaaldrich
gener
procedur
prepar
metal
sodium
g
mol
dissolv
absolut
ethanol
ml
argon
intens
stir
mechan
stirrer
reaction
flask
equip
reflux
condens
chlorocalcium
tube
sodium
dissolv
reaction
mixtur
cool
room
temperatur
guanidin
hydrochlorid
g
mol
ad
intens
stir
follow
correspond
monosubstitut
malon
acid
diester
mol
reaction
mixtur
intens
stir
due
product
solid
product
massiv
h
alreadi
practic
preclud
stir
anoth
h
absolut
ethanol
ml
ad
reaction
mixtur
reflux
h
stir
afterward
ethanol
ca
ml
evapor
vacuum
rotari
evapor
water
ml
ad
reaction
mixtur
stir
product
form
sodium
salt
almost
dissolv
obtain
mixtur
subsequ
neutral
dropwis
addit
acet
acid
result
immedi
quantit
precipit
desir
product
form
fine
solid
mixtur
subsequ
heat
reflux
min
cool
laboratori
temperatur
heat
cool
repeat
twice
get
wellfilter
solid
product
solid
product
filter
wash
water
ml
ethanol
ml
aceton
ml
product
dri
high
vacuum
day
obtain
puriti
product
prepar
manner
suffici
follow
reaction
base
analys
contain
crystallin
water
h
n
found
c
h
n
obtain
white
solid
yield
g
mp
calcd
c
h
n
h
c
h
n
found
c
h
n
obtain
white
solid
yield
g
mp
h
n
found
c
h
n
cphenyl
ch
anal
calcd
c
h
n
h
c
h
n
found
c
h
n
gener
procedur
prepar
prior
reaction
start
dri
vacuum
drier
mbar
day
crystallin
water
increas
amount
vilsmeierhaackarnold
reagent
requir
full
convers
subsequ
mmol
suspend
inert
atmospher
solut
vilsmeierhaackarnold
reagent
mmol
ml
chloroform
reaction
mixtur
subsequ
heat
reflux
h
start
materi
complet
dissolv
reaction
mixtur
cool
room
temperatur
pour
onto
ice
rapidli
neutral
satur
aqueou
nahco
solut
obtain
mixtur
quickli
transfer
separatori
funnel
immedi
extract
chloroform
ml
organ
fraction
combin
togeth
dri
mgso
filter
cm
layer
silica
gel
concentr
rotari
evapor
crude
residu
dimethylamino
methylen
amino
pyrimidin
dissolv
mixtur
ethanol
ml
aqueou
hcl
ml
reaction
mixtur
heat
h
crystallin
product
began
precipit
directli
reaction
mixtur
water
ml
ad
reaction
mixtur
intens
stir
min
precipit
product
filter
wash
waterethanol
mixtur
ml
aqueou
solut
nahco
ml
waterethanol
mixtur
ml
product
subsequ
recrystal
aqueou
ethanol
filter
wash
waterethanol
mixtur
ml
dri
high
vacuum
calcd
c
h
cl
n
c
h
cl
n
found
c
h
cl
n
anim
isol
cultiv
cell
femal
mice
inbr
strain
purchas
charl
river
deutschland
sulzfeld
germani
kept
transpar
plastic
cage
group
ten
maintain
independ
environment
air
flow
anim
cabinet
esi
flufranc
wissou
franc
light
set
h
temperatur
anim
kill
cervic
disloc
intraperiton
inject
ml
steril
salin
pool
periton
cell
collect
mice
n
individu
experi
wash
steril
salin
resuspend
cultur
medium
seed
roundbottom
micropl
costar
final
amount
cell
cellsml
cultur
maintain
co
humidifi
heraeu
incub
complet
cultur
medium
sigmaaldrich
contain
heatinactiv
fetal
bovin
serum
mm
lglutamin
lgml
gentamicin
sigma
protocol
approv
institut
ethic
committe
cell
cultur
h
presenc
test
compound
appli
either
alon
concomitantli
noenhanc
stimulu
provid
combin
murin
recombin
interferonc
ifnc
ngml
r
system
minneapoli
mn
lipopolysaccharid
lp
e
coli
ngml
sigma
variant
run
duplic
concentr
nitrit
supernat
cell
taken
measur
product
marletta
et
al
detect
individu
cellfre
sampl
incub
min
ambient
temperatur
aliquot
griess
reagent
h
po
absorb
nm
record
use
micropl
spectrophotomet
tecan
austria
nitrit
calibr
curv
use
convert
absorb
lm
nitrit
viabil
cell
determin
use
colorimetr
assay
base
cleavag
tetrazolium
salt
roch
diagnost
mannheim
germani
mitochondri
dehydrogenas
viabl
cell
cell
cultur
quadrupl
describ
h
cultur
ad
cell
kept
heraeu
incub
addit
h
optic
densiti
nm
evalu
analysi
varianc
anova
subsequ
multipl
comparison
test
graphic
present
data
done
use
prism
program
graphpad
softwar
san
diego
ca
sever
experi
perform
concentr
nitrit
well
optic
densiti
measur
viabil
cell
vari
among
experi
order
amalgam
data
variou
experi
express
percentag
control
valu
